Trial Profile
A Single Center, Open-label, Pilot Study Evaluating the Safety and Effectiveness of Subcutaneous Efalizumab in the Treatment of Oral Lichen Planus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Nov 2014
Price :
$35
*
At a glance
- Drugs Efalizumab (Primary)
- Indications Lichen planus
- Focus Therapeutic Use
- 25 Mar 2014 New trial record